| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |